ClinicalTrials.govpublic full text
Bioavailability Study of Ondansetron 16 mg Orally Disintegrating Tablets Under Fasting Conditions
healthy, bioequivalence, ondansetron odt, fasting, to determine bioequivalence under fasting conditions, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 995391
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.